Praxis Precision Medicines, Inc. (PRAX)
368.03
-7.91
(-2.10%)
USD |
NASDAQ |
Aug 24, 16:00
367.90
-0.13
(-0.04%)
After-Hours: 20:00
Praxis Precision Medicines Enterprise Value : 9.517B for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 9.517B |
| August 21, 2026 | 9.738B |
| August 20, 2026 | 9.420B |
| August 19, 2026 | 10.02B |
| August 18, 2026 | 9.567B |
| August 17, 2026 | 9.750B |
| August 14, 2026 | 9.483B |
| August 13, 2026 | 9.529B |
| August 12, 2026 | 10.03B |
| August 11, 2026 | 9.591B |
| August 10, 2026 | 9.487B |
| August 07, 2026 | 9.314B |
| August 06, 2026 | 9.576B |
| August 05, 2026 | 8.154B |
| August 04, 2026 | 7.899B |
| August 03, 2026 | 7.771B |
| July 31, 2026 | 7.836B |
| July 30, 2026 | 7.834B |
| July 29, 2026 | 7.367B |
| July 28, 2026 | 7.501B |
| July 27, 2026 | 8.059B |
| July 24, 2026 | 8.324B |
| July 23, 2026 | 8.243B |
| July 22, 2026 | 7.955B |
| July 21, 2026 | 8.116B |
| Date | Value |
|---|---|
| July 20, 2026 | 7.741B |
| July 17, 2026 | 8.020B |
| July 16, 2026 | 7.846B |
| July 15, 2026 | 8.132B |
| July 14, 2026 | 8.390B |
| July 13, 2026 | 8.024B |
| July 10, 2026 | 8.315B |
| July 09, 2026 | 8.542B |
| July 08, 2026 | 8.538B |
| July 07, 2026 | 8.286B |
| July 06, 2026 | 7.994B |
| July 02, 2026 | 8.135B |
| July 01, 2026 | 8.165B |
| June 30, 2026 | 8.589B |
| June 29, 2026 | 8.981B |
| June 26, 2026 | 8.347B |
| June 25, 2026 | 8.349B |
| June 24, 2026 | 7.821B |
| June 23, 2026 | 7.722B |
| June 22, 2026 | 7.667B |
| June 18, 2026 | 7.080B |
| June 17, 2026 | 6.737B |
| June 16, 2026 | 6.381B |
| June 15, 2026 | 6.585B |
| June 12, 2026 | 6.641B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Heron Therapeutics, Inc. | 167.90M |
| Insmed, Inc. | 26.65B |
| Ionis Pharmaceuticals, Inc. | 10.41B |
| Perspective Therapeutics, Inc. | 131.02M |
| Regeneron Pharmaceuticals, Inc. | 80.37B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -83.72M |
| Total Expenses (Quarterly) | 83.72M |
| EPS Diluted (Quarterly) | -2.874 |
| Earnings Yield | -3.52% |
| Normalized Earnings Yield | -3.517 |